Consequently, increased SERPINE1 expression after treatment correlates with shorter disease-free survival (DFS) or progression-free survival (PFS), suggesting that SERPINE1 is associated with tumor progression and may be a potential therapeutic target [50]. Here, SERPINE1 is linked to neoplasm.